Objective: to establish the number of necessary nebulizations and the need for intravenous corticosteroids in children with asthma attacks, considering the clinical and functional features showed on admission to the emergency room.
Introduction
Asthma is an important cause of pediatric assistance in emergency rooms, and accounts for a significant percentage of hospital admissions. 1, 2 This disease is still a serious public health problem all over the world and has been intensively discussed by scientists, since its prevalence, morbidity, and mortality have progressively increased over the last two decades, despite important breakthroughs in its pathogenesis. [1] [2] [3] Approximately 70% of asthma deaths occur during hospitalization, thus reinforcing the idea that most patients die because the severity of the disease is underestimated and, consequently, because of inadequate or insufficient treatment. 1, 4, 5 Treating asthma in emergency rooms always involves potentially difficult decisions on whether one should 0 1 2
Color normal paleness cyanosis
Respiratory frequency (ipm)* 1 to 2 years up to 30 31-60 above 60 2 to 5 years up to 25 26-50 above 50 older than 5 years up to 20 21-40 above 40
Use of accessory muscles none slight or moderate intense
Pulmonary auscultation wheezing at the end inspiratory and no wheezing of inspiration expiratory wheezing Cerebral function normal depressed or agitated comatose Table 1 -Clinical score used to assess the severity of asthma attacks in children admitted to the Emergency Room * The normal values were obtained from Waring W.W. 28 discharge the patient, continue the treatment, or hospitalize him/her. More often than not, this decision is taken subjectively on the basis of the physician's clinical experience. In the past few years, pulse oximetry and peak expiratory flow have been recommended for monitoring the severity of asthma attacks and the response to treatment, in an attempt to optimize assistance. [6] [7] [8] [9] [10] [11] [12] [13] [14] The Consensus Reports on the Management of Asthma [15] [16] [17] recommends aggressive treatment for asthma attacks, suggesting high doses of bronchodilators and the early use of corticosteroids. However, insufficient use of corticosteroids and underdosage or long intervals between nebulizations with beta 2-agonists are some of the problems with the management of asthma in emergency rooms. 15 This study aims at verifying whether clinical and functional abnormalities on the admission of asthmatic children to emergency rooms (ER) can define beforehand the number of nebulizations necessary to reverse bronchial obstruction, and the need for intravenous corticosteroids.
Methods
This study prospectively evaluated 130 children with asthma attacks, aged 1 to 13 years, admitted to the Pediatric intensive care unit of the Hospital de Base in São José do Rio Preto, between September 1996 and May 1997.
The recommendations by the American Thoracic Society 18 were used as inclusion criteria; in other words, children were considered asthmatic when they presented a family history of atopic disease, and at least two previous wheezing episodes, with improvement of clinical symptoms after the use of oral, parenteral, or inhaled bronchodilators.
The asthma attacks on admission were characterized by the auscultation of predominantly expiratory wheezing. Children with hemoglobinopathies, acute bronchiolitis, congenital or acquired cardiopathies, cystic fibrosis, bronchopulmonary dysplasia, and those younger than one year old were excluded from the study. The research project was evaluated and approved by the Medical Ethics Committee of the São José do Rio Preto School of Medicine, and an informed consent was signed by parents or guardians, authorizing the participation of their children in the study.
Initially, before any treatment, the author performed a physical examination and measured the arterial oxygen saturation (SaO 2 ) on every child, and the peak expiratory flow (PEF) on children aged five years or older. In the clinical evaluation, a modified clinical score based on Wood's test score was obtained, 19 including respiratory frequency, color, use of accessory muscles, lung auscultation and cerebral function. Each of these items was graded from 0 to 2 according to the intensity of the symptoms, and their sum originated the patient's score at the moment of evaluation. Table 1 shows the clinical score used. SaO 2 was measured by a pulse oximeter (Dixtal Biomédica Ltd., DX 2405, Manaus, AMl) connected to the child's forefinger or hallux with an age-specific sensor, in ambient air. SaO 2 was registered after the first minute of stabilization as the value that remained more stable during the second minute. The PEF value was obtained through a portable device, Wright peak flow meter (Clement Clarke International Ltd., London, England). In order to measure PEF, the child had to maintain an orthostatic position, without inclining the cervical region, holding the device horizontally, and trying to keep air outlets free. 20 The child then took a deep breath, placed the device in his/her mouth and closed his/her lips around the mouthpiece. After that, the child breathed out intensively and fast. This procedure was repeated three times, and the highest value obtained (expressed in absolute value) was recorded. 20, 21 Later, this value was expressed in percentage for the patient's height and sex, using the equation proposed by Torres et al. 22 After the initial evaluation, therapy and control were implemented, following the international recommendations established in 1995. 2 Patients received intermittent nebulizations with 0.15 mg/kg of a salbutamol solution at 0.5%, added to 5 ml of saline solution at 0.9%, with an oxygen flow of six liters per minute. Patients who presented SaO 2 below 91%, or who presented with a serious asthma attack, or a state of reduced consciousness, received a previous 0.01 ml/kg subcutaneous dose of terbutaline. According to the patient's clinical response and SaO 2 , nebulizations were repeated every twenty minutes, up to a maximum of two hours after the beginning of treatment, following the international recommendations established in 1995. 2 An objective criterion for determining a satisfactory response to nebulization was SaO 2 greater than or equal to 95%. Intravenous corticosteroid was indicated at two moments: after the first nebulization, when the patient presented no improvement of clinical symptoms, or after the third nebulization, in case the patient presented partial improvement of clinical symptoms, with SaO 2 < 95%. In either of these two situations, the patient received an intravenous 2mg/kg dose of methylprednisolone.
The patients were evaluated five minutes after the first, third and sixth nebulizations, during the study protocol. The values for clinical score, SaO 2 in ambient air, and PEF were recorded throughout the evaluation. Patients were discharged when, regardless of the number of nebulizations, there was significant improvement of clinical symptoms and SaO 2 greater than or eqaul to 95%. Hospitalization was indicated when, after a maximum number of 6 consecutive nebulizations, no satisfactory improvement of clinical symptoms was achieved, and SaO 2 remained below 95%. In patients with SaO 2 less than or equal to 91% after the third nebulization, hospitalization was indicated earlier.
The statistical analysis included analysis of variance, to evaluate the average behavior of the variables obtained on admission to the ER according to the number of nebulizations, and the use of corticosteroids in the emergency room. When the difference among the means for the studied parameters was significant for the groups that received one, three, or six nebulizations, Tukey's multiple comparison test was used for the analysis. 23 The use of regression analysis allowed building equations for correlating the studied variables with the number of nebulizations and the use of corticosteroids. Later on, sensitivity, specificity, and positive and negative predictive values were calculated through different initial levels of clinical scores, SaO 2 and PEF to determine the need for corticosteroids in the ER in advance.
Results
In this study, the proportion between male and female children was 1.8: 1. The means and standard deviations for age (months), height (cm), and weight (kg) were, respectively, 68.67± 39.0, 111.09 ± 20.34 and 21.24 ± 9.18. The PEF was only obtained from 56 children older than 5 years of age (87.5%); 8 children who were unwilling to help or who were suffering from a severe attack did not have their PEF assessed.
Eighty-four children (64.6%) had already received home treatment with oral or inhaled bronchodilator before participating in the study. Ten children received subcutaneous terbutaline on admission to the ER after initial evaluation.
Thirty-eight children (29.2%) were submitted to one nebulization with beta 2-agonist, 50 children (38.5%) received 3 nebulizations, and 42 (32.3%) received 6 nebulizations. Among the children who required 6 nebulizations, apparently those with a more severe asthma attack, 13 were hospitalized, and 29 were discharged from the ER. Table 2 shows the means and confidence intervals for the initial clinical score, SaO2, and % PEF (values obtained on admission to the ER), according to the number of nebulizations performed during the period the children remained in the ER. The mean for the initial clinical score among the patients who received one nebulization was lower than that of children who received three or six nebulizations. The statistical analysis through Tukey test revealed significant statistical differences among the groups that received 1, 3, and 6 nebulizations (P<0.05). The mean for initial SaO 2 among the patients who received one nebulization was higher than the mean for those who received three or six nebulizations. The statistical analysis through Tukey test showed statistically significant differences between those who received 1 or 3 nebulizations, when compared to those who received 6 nebulizations (P<0.05). There were no significant differences between the means for SaO 2 in the groups that received 1 and 3 nebulizations (P>0.05). The mean for initial % PEF among patients who received one nebulization with beta 2-agonist was higher than that of patients who received three or six nebulizations. The statistical analysis of these results through Tukey test revealed statistically significant differences between those who received 1 or 3 nebulizations when compared to those who received 6 nebulizations (P<0.05). There were no significant differences between the groups that received 1 and 3 nebulizations (P>0.05).
The use of regression analysis allowed building equations to estimate the total number of required nebulizations according to the values of clinical scores, SaO 2 , and % PEF obtained on admission to the ER. All the three variables presented a significant correlation with the number of nebulizations performed in the ER (P<0.0001). We also created an equation to estimate the total number of necessary Through these equations, it was possible to establish a practical rule that allows us to estimate the approximate number of nebulizations with beta 2-agonist, based on the initial clinical score, SaO 2 , and % PEF values. This practical rule is presented in Table 3 .
Sixty-eight children (52.3%) received corticosteroid (intravenous methylprednisolone) while treated in the ER. Table 4 shows the means and confidence intervals for the initial clinical score, SaO 2 , and % PEF according to the children's need for corticosteroids during the treatment of asthma attacks in the ER. The mean for the initial clinical score among the patients who received corticosteroid was higher than that of patients who did not receive it. In the analysis of variance, the difference between the means was highly significant (P<0.001). The mean for the initial SaO 2 among patients who received corticosteroid in the emergency room was lower than that of patients who did not receive the drug. In the analysis of variance, the difference between the means was highly significant (P<0.001). The results showed that the mean for the initial % PEF among the patients who received corticosteroid in the ER was lower than that obtained from patients who did not receive the drug. The analysis of variance showed that the difference between the means was significant (P=0.004).
The regression analysis allowed defining predictive functions for the use of corticosteroids in the ER based on the clinical score, SaO 2 , and % PEF obtained on admission and also based on the association of these laboratory parameters. These functions, with their respective success rate (SR) and error rate (ER), are shown in Table 5 . We observed that the error and success rates of the functions Table 6 -Prediction of corticosteroid use at the Emergency Room based on the initial values for clinical score, SaO 2 , and % PEF SaO 2 = arterial oxygen saturation % PEF = peak expiratory flow obtained for the prediction of corticosteroid use, based on the score and SaO 2 , were quite similar. The success rate for PEF was a bit higher, but there was also an increase in the error rate. Through these equations, it was possible to establish a practical rule that allows us to predict the need for corticosteroid use, based on the values of SaO 2 , clinical score, and % PEF obtained on admission to the ER This practical rule is shown in Table 6 .
Cutoff points for the values of clinical score, SaO 2 , and % PEF on admission to the ER were used for the calculation of sensitivity, specificity, and positive predictive value (PPV), and negative predictive value (NPV) in order to estimate the necessity for corticosteroid use. These results are presented in Table 7 .
Discussion
More than 25% of the patients with asthma attacks who are discharged after receiving assistance in the ER have a relapse and return to the ER. 17 This probably results from the lack of a standardized and adequate treatment for asthma attacks.
The treatment of asthma attacks, according to international recommendations, 2 should follow a scheme of consecutive nebulizations with beta 2-agonists every 20 minutes up to a maximum of six nebulizations, and requires frequent reevaluation. In an ER, decisions must be both fast and efficient. Due to the great number of patients in an ER, adequate treatment is usually postponed. From the practical point of view, it is crucial that the treatment of an asthmatic child regarding the number of nebulizations with beta 2agonist, and use of intravenous corticosteroids be defined on his/her admission to the ER. In our study, there was a correlation among the number of nebulizations necessary for the relief of the asthma attack and the increase of the initial clinical score values, and the reduction of initial SaO 2 and PEF values. Yamamoto et al. 24 made similar comments after assessing 7,381 asthmastricken patients younger than 21 years of age. They found out that the means for initial SaO 2 were gradually lower in those patients who required higher doses of beta 2-agonist in the ER. The same authors, in another study, made similar comments after evaluating and measuring the peak expiratory flow of 785 asthmatic patients younger than 21 years. 25 They observed that the means for initial PEF were also gradually lower in those patients who required higher doses of bronchodilator medication in the ER.
Our study allowed us to obtain regression equations that correlate the number of nebulizations with the analyzed parameters (clinical score, SaO 2 , and PEF). However, the coefficients of determination (R 2 ) of these equations were low, which does not satisfactorily explain the total variation obtained. There was a higher coefficient when the equation was obtained from the association between clinical score and saturation but, even so, the value obtained was relatively low (38.6%). In spite of this, we suggest that children admitted to the ER with a clinical score greater than or equal to 3, SaO 2 less than or equal to 96%, and PEF less than 50% of the expected values, receive at least 3 intermittent nebulizations with beta 2-agonist.
Yamamoto et al. 24 used linear regression to measure the correlation between the total number of bronchodilator administrations and the initial values of SaO 2 and PEF. Both variables showed a significant correlation with the number of nebulizations (P<0.0001), with low R 2 values (18.3% and 14.3%, respectively).
In the present study, which followed international recommendations, 2 52.3% of the patients received intravenous corticosteroid in the ER. We observed that the means for the initial clinical score of the patients who received corticosteroids was significantly higher than the mean for those who did not receive them, and that the means for initial SaO 2 and PEF were significantly lower in those patients for whom the use of corticosteroids was necessary. We verified that 100% of the children admitted to the ER, whose initial clinical score was greater than or equal to 7, and whose SaO 2 was below 91%, received corticosteroids. We did not find any study establishing criteria for the recommendation of corticosteroids in the treatment of asthma attacks, based on the values of initial clinical score, SaO 2 , and PEF, in the available literature.
Our results suggest that corticosteroids be used to treat asthma attacks in children whose initial values for clinical score are greater than or equal to 4, whose SaO 2 is below 95%, and whose PEF is below or equal to 40% of the expected value. According to the statistical analysis, the presence of 2 or 3 of these criteria reinforces the need for the early administration of corticosteroids. These levels were obtained through regression analysis, yielding high positive predictive values (PPV) and high specificity for the recommendation of corticosteroid use. This criterion allows anticipating the administration of corticosteroids on admission of asthmatic children to the ER, thus contributing to the early improvement of pulmonary function. 26 Meta-analyses aimed at assessing the benefits of corticosteroid therapy in the ER showed a significant reduction in the number of hospital admissions and relapses within five to seven days after the asthma attack resolution. 27 Considering that corticosteroids have a delayed effect, an early treatment with these drugs may be extremely beneficial in the prevention of asthma attacks. The late recommendation of corticosteroid use may hinder the prognosis of asthma attacks in children, since these drugs are fundamental to resolve new acute episodes and the intensification of the inflammatory process. 15 Physical examination is extremely important when assessing asthma attacks. However, this examination may be insufficient, and the pediatrician may not be sure whether or not he/she should use intravenous corticosteroids or how often the nebulization should be administered (one or more nebulizations). Simple and noninvasive measures, such as pulse oximetry and peak expiratory flow, may help to evaluate the intensity of an asthma attack, and to determine an adequate treatment. This may be a way to optimize the treatment of asthma attacks.
In view of the results obtained through our study, we recommend that arterial oxygen saturation and peak expiratory flow measured on admission of asthmatic children to the ER, be used in treatment decisions, especially with regard to the use of corticosteroids, which can influence the prognosis and the evolution of asthma attacks.
